Literature DB >> 2891982

Identification of an intestinal immune response using peripheral blood lymphocytes.

B D Forrest1.   

Abstract

The intestinal immune response of volunteers given the oral vaccine Salmonella typhi Ty21a was assessed with a new immunoassay which measures specific antibody secretion by peripheral blood lymphocytes (PBL). Peak IgA, IgG, and IgM production by PBL occurred on day 7 after the start of vaccination. Peak antibody secretion by PBL occurred several days earlier than the serum antibody peak. All volunteers showed a specific PBL antibody response, but serum or intestinal immune responses, when demonstrable, were highly variable. Peak PBL IgA antibody response correlated with degree of rise in IgA antibody in serum (p = 0.00098) and the intestinal fluid (p = 0.0024). The assay is a useful means of measuring humoral immune response at a mucosal surface after local administration of antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891982     DOI: 10.1016/s0140-6736(88)90284-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Appraisal of gut lavage in the study of intestinal humoral immunity.

Authors:  S O'Mahony; J R Barton; S Crichton; A Ferguson
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.

Authors:  B D Forrest
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

3.  Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09).

Authors:  B D Kirkpatrick; Matthew D Bentley; Anette M Thern; Catherine J Larsson; Cassandra Ventrone; Meera V Sreenivasan; Lou Bourgeois
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

4.  Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

Authors:  C Wennerås; A M Svennerholm; C Ahrén; C Czerkinsky
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

Authors:  A B Hartman; L L Van de Verg; H H Collins; D B Tang; N O Bendiuk; D N Taylor; C J Powell
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.

Authors:  J G Morris; T Takeda; B D Tall; G A Losonsky; S K Bhattacharya; B D Forrest; B A Kay; M Nishibuchi
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

7.  Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation.

Authors:  P V Kirjavainen; H S ElNezami; S J Salminen; J T Ahokas; P F Wright
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

8.  Protection mediated by antibodies to iron-regulated outer-membrane proteins of S. typhi in a mouse peritonitis model.

Authors:  Shaloo Sood; Praveen Rishi; Veena Dhawan; Saroj Sharma; Nirmal Kumar Ganguly
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

9.  Diagnostic approach to acute diarrheal illness in a military population on training exercises in Thailand, a region of campylobacter hyperendemicity.

Authors:  David R Tribble; Shahida Baqar; Lorrin W Pang; Carl Mason; Huo-Shu H Houng; Chittima Pitarangsi; Carlos Lebron; Adam Armstrong; Orntipa Sethabutr; John W Sanders
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

10.  Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.

Authors:  Firdausi Qadri; Edward T Ryan; A S G Faruque; Firoz Ahmed; Ashraful Islam Khan; M Monirul Islam; Syed M Akramuzzaman; David A Sack; Stephen B Calderwood
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.